Ayurvedic management of limb girdle muscular dystrophy in a twelve-year-old patient with Panchakarma and Shamana Chikitsa: a case study

Authors

  • Mangesh Bhosale PG scholar
  • Raghavendra Pandilwar MUHS, Nashik

DOI:

https://doi.org/10.52482/ayurline.v10i06.1131

Keywords:

Limb girdle muscular dystrophy, Mamsa dhatu kshaya, Panchakarma, Basti, Shashtikashali pinda sweda, Kaumarabhritya, Case study

Abstract

Background: Limb girdle muscular dystrophy is a genetically heterogeneous group of progressive muscle disorders for which no curative treatment exists, and care is largely supportive. In Ayurveda the presentation can be understood as Mamsa dhatu kshaya with Vata vitiation.

Aim and objectives: To document the Ayurvedic management of one child with limb girdle muscular dystrophy and to describe the clinical and biochemical course during hospital care.

Observations: A twelve-year-old girl presented with difficulty in rising from sitting, inability to climb stairs, frequent falls while running, a waddling gait and a positive Gowers sign. Serum creatine phosphokinase was 3528.1 at baseline, with raised liver transaminases and a low vitamin D level. Neurology and rheumatology opinions and echocardiography were obtained, and blood was sent for genome sequencing. She was admitted for 53 days and received Abhyanga with Mahanarayana taila and Mahamasha taila, Shashtikashali pinda sweda, and Basti with Bala taila, Mustadi yapana basti and Sanvardhana ghrita, together with oral Shamana formulations and nutritional supplements.

Main findings: Creatine phosphokinase measured 1429, 1123 and 1308 on repeat testing, a fall of about 63 percent from baseline at the last measurement. She was haemodynamically stable at discharge and no adverse event was recorded. Functional outcome was not quantified and the genetic diagnosis was awaited.

Conclusion: The biochemical trend is encouraging, but it cannot be attributed to the intervention in a single uncontrolled case. Structured functional scales, genetic confirmation and longer follow-up are needed in future reports.

Author Biography

Raghavendra Pandilwar, MUHS, Nashik

Associate Professor, Department of Kaumarbhritya, YMT Ayurvedic Medical College and Hospital, Kharghar, Maharashtra, India

References

1. Mercuri E, Muntoni F. Muscular dystrophies. Lancet. 2013;381(9869):845-60.

2. Straub V, Murphy A, Udd B; LGMD workshop study group. 229th ENMC international workshop: Limb girdle muscular dystrophies - nomenclature and reformed classification. Neuromuscul Disord. 2018;28(8):702-10.

3. Mah JK, Korngut L, Fiest KM, Dykeman J, Day LJ, Pringsheim T, et al. A systematic review and meta-analysis on the epidemiology of the muscular dystrophies. Can J Neurol Sci. 2016;43(1):163-77.

4. Nigro V, Savarese M. Genetic basis of limb-girdle muscular dystrophies: the 2014 update. Acta Myol. 2014;33(1):1-12.

5. Vissing J. Limb girdle muscular dystrophies: classification, clinical spectrum and emerging therapies. Curr Opin Neurol. 2016;29(5):635-41.

6. Wicklund MP. The muscular dystrophies. Continuum (Minneap Minn). 2013;19(6):1535-70.

7. Moore SA, Shilling CJ, Westra S, Wall C, Wicklund MP, Stolle C, et al. Limb-girdle muscular dystrophy in the United States. J Neuropathol Exp Neurol. 2006;65(10):995-1003.

8. Narayanaswami P, Weiss M, Selcen D, David W, Raynor E, Carter G, et al. Evidence-based guideline summary: diagnosis and treatment of limb-girdle and distal dystrophies. Neurology. 2014;83(16):1453-63.

9. Agnivesha. Charaka Samhita with Ayurveda Dipika commentary of Chakrapanidatta. Acharya JT, editor. Sutrasthana, chapter 28 (Vividhashitapitiya). Reprint ed. Varanasi: Chaukhambha Surbharati Prakashan;

10. Vagbhata. Ashtanga Hridaya with Sarvangasundara of Arunadatta and Ayurvedarasayana of Hemadri. Paradkar HS, editor. Sutrasthana, chapter 11 (Doshadivijnaniya). Edition. Varanasi: Chaukhambha Orientalia;

11. Sushruta. Sushruta Samhita with Nibandhasangraha commentary of Dalhana. Acharya JT, editor. Sutrasthana, chapter 15 (Doshadhatumalakshayavriddhivijnaniya). Edition. Varanasi: Chaukhambha Sanskrit Sansthan;

12. Sushruta. Sushruta Samhita with Nibandhasangraha commentary of Dalhana. Acharya JT, editor. Sutrasthana, chapter 24 (Vyadhisamuddeshiya). Edition. Varanasi: Chaukhambha Sanskrit Sansthan;

13. Agnivesha. Charaka Samhita with Ayurveda Dipika commentary of Chakrapanidatta. Acharya JT, editor. Chikitsasthana, chapter 28 (Vatavyadhi chikitsa). Reprint ed. Varanasi: Chaukhambha Surbharati Prakashan;

14. Vagbhata. Ashtanga Hridaya with Sarvangasundara of Arunadatta and Ayurvedarasayana of Hemadri. Paradkar HS, editor. Sutrasthana, chapter 19 (Bastividhi). Edition. Varanasi: Chaukhambha Orientalia;

15. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D; CARE Group. The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol. 2014;67(1):46-51.

16. Agnivesha. Charaka Samhita with Ayurveda Dipika commentary of Chakrapanidatta. Acharya JT, editor. Siddhisthana, chapter 1 (Kalpanasiddhi). Reprint ed. Varanasi: Chaukhambha Surbharati Prakashan;

17. Govinddas Sen. Bhaishajya Ratnavali. Vatavyadhi chikitsa adhikara. Editor or commentator, edition. Varanasi: Publisher;

18. Sahasrayogam. Kashaya prakarana. Editor or translator, edition. City: Publisher; year. p. __

19. Singh N, Bhalla M, de Jager P, Gilca M. An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda. Afr J Tradit Complement Altern Med. 2011;8(5 Suppl):208-13.

20. Kyriakides T, Angelini C, Schaefer J, Sacconi S, Siciliano G, Vilchez JJ, et al. EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia. Eur J Neurol. 2010;17(6):767-73.

21. Nathwani RA, Pais S, Reynolds TB, Kaplowitz N. Serum alanine aminotransferase in skeletal muscle diseases. Hepatology. 2005;41(2):380-2.

22. Delanaye P, Cavalier E, Pottel H. Serum creatinine: not so simple! Nephron. 2017;136(4):302-8.

23. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-30.

24. Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 2018;17(4):347-61.

25. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010;9(1):77-93.

26. Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018;17(3):251-67.

27. Chopra A, Doiphode VV. Ayurvedic medicine: core concept, therapeutic principles, and current relevance. Med Clin North Am. 2002;86(1):75-89.

Published

04-10-2026

How to Cite

Bhosale, M., & Raghavendra Pandilwar. (2026). Ayurvedic management of limb girdle muscular dystrophy in a twelve-year-old patient with Panchakarma and Shamana Chikitsa: a case study. Ayurline: International Journal of Research in Indian Medicine, 10(06). https://doi.org/10.52482/ayurline.v10i06.1131

Similar Articles

<< < 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 > >> 

You may also start an advanced similarity search for this article.